出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年11月
血管パッチ市場 : 材料（生物学的、合成）、用途（腹部大動脈瘤の開腹修復、先天性心疾患、頸動脈内膜切除術）、エンドユーザー（病院、外来手術センター） – 2027年までの世界予測
Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) – Global Forecast to 2027
| ページ数 | 133 |
| 図表数 | 128 |
| 種別 | 英文調査報告書 |
| 価格 |
The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. Market growth is driven by factors such as the rising incidence of CVD, the rise in the volume of surgical procedures, coupled with the increasing adoption of biological patches for vascular surgeries.
“The biologic vascular patches held the largest share of the vascular patches market, by material”
Based on material, the global vascular patches market is segmented into biological and synthetic vascular patches. Biologic vascular patches held a significant share in the market. It is also the fastest-growing material segment in this market. Growth in this segment is primarily driven by the advantages offered by the biologic patches over their synthetic counterparts.
“The vascular bypass surgery segment is the fastest growing segment of the vascular patches market, by application”
Based on application, the vascular patches market is segmented into carotid endarterectomy (CEA), open repair of abdominal aortic aneurysm (AAA), congenital heart diseases, vascular bypass surgery, and other applications. The vascular bypass surgery is expected to witness the fastest growth during the forecast period. The high growth rate of vascular bypass surgery can be attributed to the availability of reimbursement in emerging and developed economies.
“Among the end users, the hospitals segment is anticipated to register the highest growth during the forecast period”
Based on end users, the vascular patches market is segmented into hospitals and ambulatory surgical centers. The hospitals segment is anticipated to witness growth at the highest rate during the forecast period. The growth can be attributed to the increasing number of hospitals offering better healthcare services and infrastructure.
“The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global vascular patches market is segmented into four regions – North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is expected to witness the highest growth in the vascular patches market during the forecast period. The high growth in this region can primarily be attributed to the large number of target population, and improved healthcare infrastructures in Southeast Asian countries.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 30%, Tier 2 – 45%, and Tier 3 – 25%
• By Designation: C-level – 28%, D-level – 32%, and Others – 40%
• By Region: North America – 35%, Europe – 21%, Asia Pacific – 28%, Rest of the World – 16%
Lists of Companies Profiled in the Report:
• Baxter International, Inc. (US)
• LeMaitre Vascular, Inc. (US)
• W. L. Gore & Associates, Inc. (US)
• Getinge AB (Sweden)
• B Braun (Germany)
• Artivion, Inc (US)
• Edwards Lifesciences Corporation (US)
• Aziyo Biologics, Inc. (US)
• Terumo Corporation (Japan)
• BD (US)
• Labcor Laboratórios Ltda. (Brazil)
• VUP Medical (Czech Republic)
• Aegis Lifesciences (India)
• SynkroMax Biotech Pvt. Ltd. (India)
Research Coverage:
This report provides a detailed picture of the global vascular patches market. It aims at estimating the size and future growth potential of the market across different segments, such as material, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall vascular patches market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
目次
1 INTRODUCTION 19
1.1 STUDY OBJECTIVES 19
1.2 MARKET DEFINITION 19
1.2.1 INCLUSIONS & EXCLUSIONS 20
1.3 MARKET SCOPE 20
FIGURE 1 VASCULAR PATCHES MARKET 20
1.3.1 YEARS CONSIDERED 21
1.4 CURRENCY CONSIDERED 21
1.5 STAKEHOLDERS 21
1.6 SUMMARY OF CHANGES 21
1.7 LIMITATIONS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
FIGURE 2 RESEARCH DESIGN 23
2.1.1 SECONDARY SOURCES 23
2.1.1.1 Secondary sources 25
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 26
2.1.2.2 Key industry insights 27
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
2.2 MARKET SIZE ESTIMATION 28
2.2.1 BOTTOM-UP APPROACH 29
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 29
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 30
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 30
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
FIGURE 8 DATA TRIANGULATION METHODOLOGY 31
2.4 MARKET SHARE ANALYSIS 32
2.5 STUDY ASSUMPTIONS 32
2.6 RISK ASSESSMENT 32
TABLE 1 RISK ASSESSMENT: VASCULAR PATCHES MARKET 32
2.7 LIMITATIONS 33
2.7.1 METHODOLOGY-RELATED LIMITATIONS 33
2.7.2 SCOPE-RELATED LIMITATIONS 33
2.8 GROWTH RATE ASSUMPTIONS 33
3 EXECUTIVE SUMMARY 34
FIGURE 9 VASCULAR PATCHES MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION) 34
FIGURE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 35
FIGURE 11 VASCULAR PATCHES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 35
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF VASCULAR PATCHES MARKET 36
4 PREMIUM INSIGHTS 37
4.1 VASCULAR PATCHES MARKET OVERVIEW 37
FIGURE 13 RISING PREVALENCE OF CVD AND GROWING VOLUME OF CARDIOVASCULAR SURGERIES TO DRIVE MARKET 37
4.2 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL (2021) 38
FIGURE 14 BIOLOGICAL VASCULAR PATCHES ACCOUNTED FOR LARGEST SHARE IN 2021 38
4.3 VASCULAR PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 39
4.4 VASCULAR PATCHES MARKET: GEOGRAPHIC MIX 39
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 39
4.5 VASCULAR PATCHES MARKET: DEVELOPED VS. EMERGING ECONOMIES 40
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
FIGURE 18 VASCULAR PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
5.2.1 DRIVERS 42
5.2.1.1 Rising incidence of CVD 42
5.2.1.2 Growing geriatric population and subsequent prevalence of vascular diseases 42
5.2.1.3 Rising number of cardiovascular surgeries worldwide 43
5.2.1.4 Availability of reimbursement for vascular procedures 43
5.2.1.5 Growing adoption of biological patches 44
5.2.2 RESTRAINTS 44
5.2.2.1 High procedural cost of vascular surgeries and associated products 44
5.2.2.2 Product failures and recalls 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Emerging economies 45
5.2.3.2 Growth in the number of hospitals & surgical centers 45
5.2.4 CHALLENGES 46
5.2.4.1 Lack of skilled professionals 46
5.3 REGULATORY LANDSCAPE 46
TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 46
TABLE 3 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 47
TABLE 4 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 47
TABLE 5 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 47
5.3.1 NORTH AMERICA 48
5.3.1.1 US 48
5.3.1.2 Canada 48
5.3.2 EUROPE 48
5.3.3 ASIA PACIFIC 48
5.3.3.1 China 48
5.3.3.2 Japan 48
5.3.3.3 India 48
5.3.4 LATIN AMERICA 49
5.3.4.1 Brazil 49
5.3.4.2 Mexico 49
5.3.5 MIDDLE EAST 49
5.3.6 AFRICA 50
5.4 PORTER’S FIVE FORCES ANALYSIS 50
TABLE 6 VASCULAR PATCHES MARKET: PORTER’S FIVE FORCES ANALYSIS 50
5.4.1 THREAT FROM NEW ENTRANTS 50
5.4.2 THREAT FROM SUBSTITUTES 50
5.4.3 BARGAINING POWER OF BUYERS 50
5.4.4 BARGAINING POWER OF SUPPLIERS 51
5.4.5 DEGREE OF COMPETITION 51
5.5 TECHNOLOGY ANALYSIS 51
5.6 VALUE CHAIN ANALYSIS 51
5.7 SUPPLY CHAIN ANALYSIS 52
FIGURE 19 VASCULAR PATCHES MARKET: SUPPLY CHAIN ANALYSIS 53
5.8 ECOSYSTEM ANALYSIS 53
FIGURE 20 VASCULAR PATCHES MARKET: ECOSYSTEM ANALYSIS 54
5.8.1 ECOSYSTEM ROLE 54
6 VASCULAR PATCHES MARKET, BY MATERIAL 55
6.1 INTRODUCTION 56
TABLE 7 VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 56
6.2 BIOLOGIC VASCULAR PATCHES 56
6.2.1 WIDE USAGE IN ARTERIAL CLOSURE DURING CARDIAC SURGERIES TO DRIVE MARKET 56
TABLE 8 BIOLOGIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 57
6.3 SYNTHETIC VASCULAR PATCHES 57
6.3.1 HIGH RISK OF INFECTION DESPITE BEING COST-EFFICIENT TO RESTRAIN MARKET 57
TABLE 9 SYNTHETIC VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 57
7 VASCULAR PATCHES MARKET, BY APPLICATION 58
7.1 INTRODUCTION 59
TABLE 10 VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59
7.2 CAROTID ENDARTERECTOMY 59
7.2.1 INCREASING PATCH ANGIOPLASTY PROCEDURES TO DRIVE MARKET 59
TABLE 11 VASCULAR PATCHES MARKET FOR CAROTID ENDARTERECTOMY, BY REGION, 2020–2027 (USD MILLION) 60
7.3 VASCULAR BYPASS SURGERY 60
7.3.1 RISING PREVALENCE OF VASCULAR DISEASES TO DRIVE MARKET 60
TABLE 12 VASCULAR PATCHES MARKET FOR VASCULAR BYPASS SURGERY, BY REGION, 2020–2027 (USD MILLION) 60
7.4 CONGENITAL HEART DISEASE 61
7.4.1 USE OF SYNTHETIC & BIOLOGIC VASCULAR PATCHES FOR CORRECTIVE SURGERIES TO DRIVE MARKET 61
TABLE 13 VASCULAR PATCHES MARKET FOR CONGENITAL HEART DISEASE, BY REGION, 2020–2027 (USD MILLION) 61
7.5 OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM 61
7.5.1 RISING INCIDENCE OF AAA TO DRIVE DEMAND FOR VASCULAR PATCHES 61
TABLE 14 VASCULAR PATCHES MARKET FOR OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM, BY REGION, 2020–2027 (USD MILLION) 62
7.6 OTHER APPLICATIONS 62
TABLE 15 VASCULAR PATCHES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 63
8 VASCULAR PATCHES MARKET, BY END USER 64
8.1 INTRODUCTION 65
TABLE 16 VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 65
8.2 HOSPITALS 65
8.2.1 RISING BURDEN OF CVD AND DEVELOPING INFRASTRUCTURE IN EMERGING ECONOMIES TO DRIVE MARKET 65
TABLE 17 VASCULAR PATCHES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 66
8.3 AMBULATORY SURGICAL CENTERS 66
8.3.1 RISING NUMBER OF ASCS TO PROPEL MARKET GROWTH 66
TABLE 18 VASCULAR PATCHES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION) 66
9 VASCULAR PATCHES MARKET, BY REGION 67
9.1 INTRODUCTION 68
TABLE 19 VASCULAR PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 68
9.2 NORTH AMERICA 68
FIGURE 21 NORTH AMERICA: VASCULAR PATCHES MARKET SNAPSHOT 69
TABLE 20 NORTH AMERICA: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69
TABLE 21 NORTH AMERICA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 70
TABLE 22 NORTH AMERICA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70
TABLE 23 NORTH AMERICA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 70
9.2.1 US 71
9.2.1.1 Favorable government reimbursements for vascular surgeries to drive market 71
TABLE 24 US: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 71
TABLE 25 US: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 71
TABLE 26 US: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 72
9.2.2 CANADA 72
9.2.2.1 High incidence of vascular diseases to support market growth 72
TABLE 27 CANADA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 72
TABLE 28 CANADA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73
TABLE 29 CANADA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 73
9.3 EUROPE 73
TABLE 30 EUROPE: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
TABLE 31 EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 74
TABLE 32 EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74
TABLE 33 EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 75
9.3.1 GERMANY 75
9.3.1.1 Presence of a large target patient population to support market growth 75
TABLE 34 GERMANY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 75
TABLE 35 GERMANY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76
TABLE 36 GERMANY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 76
9.3.2 FRANCE 76
9.3.2.1 High prevalence of CVD to drive demand for vascular patches 76
TABLE 37 FRANCE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 77
TABLE 38 FRANCE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77
TABLE 39 FRANCE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 77
9.3.3 UK 78
9.3.3.1 Rising geriatric population and subsequent prevalence of CHD to drive market 78
TABLE 40 UK: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 78
TABLE 41 UK: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79
TABLE 42 UK: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 79
9.3.4 ITALY 79
9.3.4.1 Increasing incidence of CHD to support market growth 79
TABLE 43 ITALY: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 80
TABLE 44 ITALY: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80
TABLE 45 ITALY: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 80
9.3.5 SPAIN 81
9.3.5.1 Rising risk of developing CVD due to age-related disorders to support market growth 81
TABLE 46 SPAIN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 81
TABLE 47 SPAIN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81
TABLE 48 SPAIN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 82
9.3.6 REST OF EUROPE 82
TABLE 49 REST OF EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 82
TABLE 50 REST OF EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83
TABLE 51 REST OF EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 83
9.4 ASIA PACIFIC 83
FIGURE 22 ASIA PACIFIC: VASCULAR PATCHES MARKET SNAPSHOT (2021) 84
TABLE 52 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 53 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 85
TABLE 54 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85
TABLE 55 ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 86
9.4.1 CHINA 86
9.4.1.1 Rising prevalence of chronic heart diseases to drive market 86
TABLE 56 CHINA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 86
TABLE 57 CHINA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
TABLE 58 CHINA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 87
9.4.2 JAPAN 87
9.4.2.1 Rising public healthcare spending to drive demand for vascular patches 87
TABLE 59 JAPAN: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 88
TABLE 60 JAPAN: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 88
TABLE 61 JAPAN: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 88
9.4.3 INDIA 89
9.4.3.1 Rising incidence of CVD to drive market 89
TABLE 62 INDIA: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 89
TABLE 63 INDIA: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89
TABLE 64 INDIA: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 90
9.4.4 REST OF ASIA PACIFIC 90
TABLE 65 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 91
TABLE 66 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91
TABLE 67 REST OF ASIA PACIFIC: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 91
9.5 REST OF THE WORLD 92
TABLE 68 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 92
TABLE 69 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 70 REST OF THE WORLD: VASCULAR PATCHES MARKET, BY END USER, 2020–2027 (USD MILLION) 93
10 COMPETITIVE LANDSCAPE 94
10.1 OVERVIEW 94
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 94
TABLE 71 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS 94
10.3 REVENUE SHARE ANALYSIS 95
FIGURE 23 VASCULAR PATCHES MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS 96
10.4 MARKET SHARE ANALYSIS 96
TABLE 72 VASCULAR PATCHES MARKET: DEGREE OF COMPETITION 96
FIGURE 24 VASCULAR PATCHES MARKET SHARE ANALYSIS, 2021 97
10.5 COMPANY EVALUATION QUADRANT 98
10.5.1 STARS 98
10.5.2 EMERGING LEADERS 98
10.5.3 PERVASIVE PLAYERS 98
10.5.4 PARTICIPANTS 98
FIGURE 25 VASCULAR PATCHES MARKET: COMPANY EVALUATION QUADRANT (2021) 99
10.6 COMPANY FOOTPRINT ANALYSIS 99
TABLE 73 COMPANY FOOTPRINT 99
TABLE 74 COMPANY MATERIAL FOOTPRINT 100
TABLE 75 COMPANY REGIONAL FOOTPRINT 101
10.7 COMPETITIVE SCENARIO 102
10.7.1 DEALS 102
TABLE 76 VASCULAR PATCHES MARKET: DEALS, 2019–2022 102
10.7.2 OTHER DEVELOPMENTS 102
TABLE 77 VASCULAR PATCHES MARKET: OTHER DEVELOPMENTS, 2019–2022 102
11 COMPANY PROFILES 103
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS 103
11.1.1 BAXTER INTERNATIONAL, INC. 103
TABLE 78 BAXTER INTERNATIONAL, INC: COMPANY OVERVIEW 103
FIGURE 26 BAXTER INTERNATIONAL, INC: COMPANY SNAPSHOT (2021) 104
11.1.2 LEMAITRE VASCULAR, INC. 106
TABLE 79 LEMAITRE VASCULAR, INC: COMPANY OVERVIEW 106
FIGURE 27 LEMAITRE VASCULAR, INC: COMPANY SNAPSHOT (2021) 106
11.1.3 W. L. GORE & ASSOCIATES, INC. 108
TABLE 80 W. L. GORE & ASSOCIATES: COMPANY OVERVIEW 108
11.1.4 GETINGE AB 110
TABLE 81 GETINGE AB: COMPANY OVERVIEW 110
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2021) 110
TABLE 82 EXCHANGE RATES UTILIZED FOR CONVERSION OF SEK TO USD 111
11.1.5 B. BRAUN 112
TABLE 83 B. BRAUN: COMPANY OVERVIEW 112
FIGURE 29 B. BRAUN: COMPANY SNAPSHOT (2021) 113
TABLE 84 EXCHANGE RATES UTILIZED FOR CONVERSION OF EUROS TO USD 113
11.1.6 EDWARDS LIFESCIENCES CORPORATION 115
TABLE 85 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 115
FIGURE 30 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021) 116
11.1.7 BECTON, DICKINSON AND COMPANY 117
TABLE 86 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 117
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 118
11.1.8 AZIYO BIOLOGICS, INC. 119
TABLE 87 AZIYO BIOLOGICS, INC: COMPANY OVERVIEW 119
FIGURE 32 AZIYO BIOLOGICS, INC: COMPANY SNAPSHOT (2021) 119
11.1.9 TERUMO CORPORATION 121
TABLE 88 TERUMO CORPORATION: COMPANY OVERVIEW 121
FIGURE 33 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 122
TABLE 89 EXCHANGE RATES UTILIZED FOR CONVERSION OF YEN TO USD 122
11.1.10 ARTIVION, INC. 124
TABLE 90 ARTIVION, INC.: COMPANY OVERVIEW 124
FIGURE 34 ARTIVION, INC: COMPANY SNAPSHOT (2021) 124
11.1.11 LABCOR LABORATÓRIOS LTDA. 126
TABLE 91 LABCOR LABORATÓRIOS LTDA.: COMPANY OVERVIEW 126
11.2 OTHER PLAYERS 127
11.2.1 VUP MEDICAL 127
TABLE 92 VUP MEDICAL: COMPANY OVERVIEW 127
11.2.2 AEGIS LIFESCIENCES 127
TABLE 93 AEGIS LIFESCIENCES: COMPANY OVERVIEW 127
11.2.3 SYNKROMAX BIOTECH PVT. LTD. 128
TABLE 94 SYNKROMAX BIOTECH PVT. LTD: COMPANY OVERVIEW 128
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX 129
12.1 INDUSTRY EXPERT INSIGHTS 129
12.2 DISCUSSION GUIDE 130
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 133
12.4 CUSTOMIZATION OPTIONS 135
12.5 RELATED REPORTS 135
12.6 AUTHOR DETAILS 136